Zajištění léků pro pacientky s rakovinou prsu

The director of the State Institute for Drug Control (SÚKL), Tomáš Boráň, commented on the availability of the drug Tamoxifen. He discussed this topic during the broadcast of the Studio 24 program on Czech Television. Tamoxifen is an important medicinal product for breast cancer patients. According to his statement, further supplies of this drug should arrive in the Czech Republic in the coming days. This should ensure its availability for patients in need. The full video of the interview is available for viewing on Czech Television's iVysílání.